Shou-wei Li

Building 1, Ward 6, Xiang Shan Yi Ke Song Road 50
Haidian, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Development and Validation of a Nomogram Model Based on Hematological Indicators for Predicting the Prognosis of Diffused Gliomas.

Development and Validation of a Nomogram Model Based on Hematological Indicators for Predicting the Prognosis of Diffused Gliomas.

Journal: Frontiers in surgery
Published: October 27, 2021

MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.

MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.

Journal: Journal for immunotherapy of cancer
Published: September 09, 2021

Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas.

Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas.

Journal: Aging
Published: November 20, 2020

Neutrophil depletion enhances the therapeutic effect of PD-1 antibody on glioma.

Neutrophil depletion enhances the therapeutic effect of PD-1 antibody on glioma.

Journal: Aging
Published: December 17, 2019

Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas.

Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas.

Journal: Scientific reports
Published: June 27, 2019

Sanbo Scoring System, Based on Age and Pre-treatment Hematological Markers, is a Non-invasive and Independent Prognostic Predictor for Patients with Primary Glioblastomas: A Retrospective Multicenter Study.

Sanbo Scoring System, Based on Age and Pre-treatment Hematological Markers, is a Non-invasive and Independent Prognostic Predictor for Patients with Primary Glioblastomas: A Retrospective Multicenter Study.

Journal: Journal of Cancer
Published: January 11, 2019

Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival.

Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival.

Journal: Frontiers in pharmacology
Published: June 06, 2018

Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies.

Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies.

Journal: Oncoimmunology
Published: May 04, 2018

Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1R132H mutation and may predict better prognosis among glioblastomas without the IDH1 mutation and ATRX loss.

Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1R132H mutation and may predict better prognosis among glioblastomas without the IDH1 mutation and ATRX loss.

Journal: Journal of clinical pathology
Published: January 04, 2018

Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas.

Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas.

Journal: Journal of Cancer
Published: January 03, 2018

Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.

Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.

Journal: Journal of neuroinflammation
Published: December 29, 2017

Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis.

Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis.

Journal: Frontiers in pharmacology
Published: August 25, 2017
Showing 1-12 of 17

Last Updated: 09/26/2026